Alpha Cognition (ACOG) Expected to Release Quarterly Earnings on Thursday

Alpha Cognition (NASDAQ:ACOG) is projected to post its Q2 2026 results after the market closes on Thursday, August 13th. Analysts expect Alpha Cognition to announce earnings of ($0.39) per share and revenue of $4.3840 million for the quarter. Parties are encouraged to explore the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 13, 2026 at 4:30 PM ET.

Alpha Cognition (NASDAQ:ACOG) last released its quarterly earnings results on Thursday, May 14th. The company reported ($0.37) EPS for the quarter, topping the consensus estimate of ($0.41) by $0.04. The business had revenue of $3.53 million during the quarter, compared to analyst estimates of $3.42 million. Alpha Cognition had a negative net margin of 232.23% and a negative return on equity of 58.35%. On average, analysts expect Alpha Cognition to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Alpha Cognition Stock Down 2.6%

Shares of NASDAQ:ACOG opened at $8.89 on Tuesday. The company has a market cap of $193.54 million, a PE ratio of -6.59 and a beta of 2.30. The company’s 50-day moving average price is $7.52 and its 200 day moving average price is $6.44. Alpha Cognition has a fifty-two week low of $4.50 and a fifty-two week high of $10.10.

Hedge Funds Weigh In On Alpha Cognition

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ACOG. Geode Capital Management LLC purchased a new position in Alpha Cognition during the 2nd quarter worth approximately $112,000. Marshall Wace LLP purchased a new stake in shares of Alpha Cognition in the second quarter valued at $600,000. Cable Car Capital LP boosted its position in shares of Alpha Cognition by 68.8% in the second quarter. Cable Car Capital LP now owns 869,002 shares of the company’s stock worth $8,108,000 after buying an additional 354,278 shares during the period. Massar Capital Management LP acquired a new stake in shares of Alpha Cognition in the second quarter worth $116,000. Finally, Manatuck Hill Partners LLC boosted its position in shares of Alpha Cognition by 74.6% in the second quarter. Manatuck Hill Partners LLC now owns 117,000 shares of the company’s stock worth $1,092,000 after buying an additional 50,000 shares during the period.

Analyst Upgrades and Downgrades

Several research analysts have commented on ACOG shares. Maxim Group started coverage on shares of Alpha Cognition in a research report on Friday, May 29th. They issued a “buy” rating and a $12.00 target price for the company. Raymond James Financial initiated coverage on Alpha Cognition in a research report on Friday, July 10th. They set an “outperform” rating and a $20.00 price objective for the company. HC Wainwright reissued a “buy” rating and issued a $18.00 price objective on shares of Alpha Cognition in a report on Friday, May 22nd. Wall Street Zen cut Alpha Cognition from a “hold” rating to a “sell” rating in a research report on Saturday, May 2nd. Finally, Craig Hallum initiated coverage on Alpha Cognition in a research note on Friday, April 17th. They set a “buy” rating and a $14.00 target price on the stock. Four equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Alpha Cognition presently has a consensus rating of “Buy” and an average price target of $16.00.

About Alpha Cognition

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.